Coya Therapeutics, Inc.
COYA
Revenue
3.43M
▲3.30M▲2600.51%
3 Months ChangeAssets
39.94M
▲2.55M▲6.81%
3 Months ChangeLiabilities
4.68M
▼-318.41k▼-6.37%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248755
2024-10-29
Form 8-K
ID: 0001193125-24-246171
2024-10-22
Form 8-K
ID: 0001193125-24-240775
2024-08-19
Form 8-K
ID: 0001193125-24-202551
2024-08-12
Form 10-Q
ID: 0000950170-24-095075
2024-08-12
Form 8-K
ID: 0000950170-24-095072
2024-07-15
Form 8-K
ID: 0001193125-24-178809
2024-06-05
Form 8-K
ID: 0001193125-24-154729
2024-05-20
Form 8-K
ID: 0001193125-24-142950
2024-05-09
Form 10-Q
ID: 0000950170-24-057056